Production Team Manager - Fill & Finish
About the job
- At least 3 years of experience as a frontline manager in industry, ideally in the pharmaceutical, cosmetics, chemical, or agri-food sector.
- Higher education.
- Knowledge of Good Manufacturing Practices is desirable rather than required.
- Direct, coordinate, and lead a team to deliver the activity's production programs while complying with Good Manufacturing Practices, hygiene and safety rules, required quantities, and deadlines.
- Improve the productivity and responsiveness of the assigned sector.
- Execute and optimize activities in compliance with applicable standards and procedures.
- Encourage and motivate employees and receive their requests and needs to support the development of their skills within the team.
- Maintain and strengthen the manager's own competency level and that of employees in line with the job requirements and evolving techniques and processes.
- Ensure effective upward, downward, and cross-functional circulation of information.
- Comply with and enforce hygiene and safety conditions.
- Ensure traceability of operations and enforce Good Manufacturing Practices through monitoring and field presence.
- Maintain and improve documentation related to the activity.
- Knowledge of Good Manufacturing Practices.
About the company
LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Courcebœufs, France
Founded
1994
Get referred to LFB
See people who can refer or advise you
Simplify's Take
What believers are saying
- Arras released first medicines in 2025, proving commercialization after heavy capital spending.
- LFB signed a 2026 collaboration with Sartorius to accelerate client programs and GMP manufacturing.
- France 2030 funding and the 2026 Alès expansion add capacity and roughly fifty jobs.
What critics are saying
- EFS must raise plasma collections to 1.4 million liters by 2028 or Arras underutilizes.
- LFB BIOMANUFACTURING still depends on Sartorius for cell line development, limiting full-stack control.
- A single French industrial base creates existential exposure to contamination, recalls, or regulatory shutdowns.
What makes LFB unique
- French state-owned sole domestic plasma fractionator anchors national medicine supply.
- Arras plant, authorized in 2025, centralizes production and triples plasma-derived capacity.
- Europlasma and Amber Plasma give LFB 24 Central European collection centers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- 401(k) Retirement Plan
- Remote Work Options
- Unlimited Paid Time Off
- Flexible Work Hours
- Paid Vacation
- Hybrid Work Options
- Wellness Program
- Mental Health Support
- Phone/Internet Stipend
- Home Office Stipend
- Stock Options